Guided Therapeutics (GTHP) Assets Average (2012 - 2025)

Guided Therapeutics (GTHP) has 14 years of Assets Average data on file, last reported at $1.1 million in Q4 2025.

• For the quarter ending Q4 2025, Assets Average fell 15.23% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $1.1 million (down 15.23% YoY), and the FY2025 full-year result was $1.4 million, down 11.32% from the prior year.
• Assets Average rose to $1.1 million in Q4 2025, from $921500.0 in the prior quarter.
• In the past five years, Assets Average ranged from a high of $3.6 million in Q4 2022 to a low of $921500.0 in Q3 2025.
• A 5-year average of $1.9 million and a median of $1.9 million in 2021 frame the typical range for Assets Average.
• Across the five-year window, Assets Average surged 239.13% in 2021 and slumped 51.0% in 2023, its largest moves.
• Tracing GTHP's Assets Average over 5 years: stood at $1.9 million in 2021, then surged by 91.25% to $3.6 million in 2022, then tumbled by 51.0% to $1.8 million in 2023, then fell by 25.92% to $1.3 million in 2024, then slipped by 15.23% to $1.1 million in 2025.
• Business Quant data shows GTHP's Assets Average at $1.1 million in Q4 2025, $921500.0 in Q3 2025, and $953500.0 in Q2 2025.